In these studies, a single injection of the vaccine induced measles hemagglutination-inhibition (HI) antibodies in 95%, mumps neutralising antibodies in 96%, and rubella HI antibodies in 99% of susceptible persons.
Nendes uuringutes tekitas vaktsiini üks süst leetrite hemaglutinatsiooni inhibitsiooni (HI) antikehad 95% - l, mumpsi neutraliseerivad antikehad 96% - l ja punetiste HI antikehad 99% - l haigustundlikest isikutest.